Success in biopharma is shifting toward leaner teams, disciplined execution, and go-to-market clarity. Cash efficiency is essential. So are proven modalities: monoclonal antibodies, small molecules, RNA, not the platform excesses of the last cycle. This is what a...
Or Why Top Recruiters Often Get Overlooked and Mediocre Ones Flourish in Many Organizations Some of the best recruiters I know are unemployed right now. Some of the worst or least capable are fully employed and getting promoted. What gives? Yes, there are plenty of...
The Case for Change Most executive search fee structures aren’t aligned with performance or client success. The traditional front-loaded ⅓ + ⅓ + ⅓ at 30% model rewards predictability for the firm, not outcomes for the client. In practice, most firms collect nearly...
If there’s one thing business owners and investors despise, it’s unpredictability. The once‑reliable rhythm of market cycles has been jolted by the global financial crisis of 2008, the COVID‑19 pandemic, and tariff‑driven geopolitical instability. Reports from both...
Why This Decision Matters With layoffs back in the headlines, talent‑acquisition consultants feel the same uncertainty their candidates do. Many contemplate “going solo” and taking direct recruiting contracts, but running a one‑person shop means handling quarterly...
